Position in HALO
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$510,320
+$80,208 QoQ
Shares Held
6,520
-2.0% QoQ
Ownership
0.006%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
#374
of 647 holders
Holding Since
Jun 2023
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in HALO Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026CSS LLC/IL holds $23,782,728 across 16 Biotechnology names. HALO ranks #5 (2.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | IONS |
Ionis Pharmaceuticals Inc
|
152,289 | $12,074,994 | |
| 2 | JAZZ |
Jazz Pharmaceuticals plc
|
29,041 | $6,998,009 | |
| 3 | BMRN |
Biomarin Pharmaceutical Inc
|
22,580 | $1,292,027 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,820 | $1,134,842 | |
| 5 | HALO |
Halozyme Therapeutics, Inc.
This page
|
6,520 | $510,320 | |
| 6 | TVTX |
Travere Therapeutics, Inc.
|
8,470 | $481,180 | |
| 7 | EXEL |
Exelixis, Inc.
|
8,709 | $473,856 | |
| 8 | INCY |
Incyte Corp
|
3,856 | $437,116 |
All Filings in HALO
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $510,320 | 6,520 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $430,112 | 6,655 | Shares | Sole | 2026-05-15 | |
| 2023-06-30 | $385,949 | 10,700 | Shares | Sole | 2023-08-14 | |
| No filing history on record for this holder in this stock. | ||||||